Work

Abstract 1983: Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-1983

Authors: Carmelina Charalambous, Ronak H. Shah, Michael F. Berger, Sujana Movva

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409625444

Cites:

Cited by:

Related to: 10